Suppr超能文献

机械取栓治疗超过最后已知时间 16 小时的大血管闭塞患者。

Mechanical Thrombectomy Treatment More than 16 h after Last Known Well for Patients with Large Vessel Occlusion.

机构信息

Department of Neurology, Nippon Medical School, Tokyo, Japan.

出版信息

Cerebrovasc Dis Extra. 2023;13(1):69-74. doi: 10.1159/000531153. Epub 2023 Jun 1.

Abstract

INTRODUCTION

Mechanical thrombectomy (MT) has been reported to be effective within 24 h after last known well (LKW) by the DAWN (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo) trial and within 16 h after LKW by the DEFUSE-3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) trial. However, there have been few reports of MT more than 16 h after LKW, and the efficacy and safety of MT more than 24 h after LKW have not yet been demonstrated. We evaluated the efficacy and safety of MT more than 16 h after LKW.

METHODS

Using data from the Nippon Medical School Hospital MT registry from April 2011 to August 2022, consecutive patients with anterior circulation large vessel occlusion (LVO) and prehospital modified Rankin scale (mRS) scores of 0-3 were enrolled. Patients were classified into the following three groups: early group (LKW <6 h), middle group (LKW 6-16 h), and late group (LKW >16 h). The clinical characteristics and outcomes were compared among these three groups.

RESULTS

Among 778 patients in the MT registry, 624 were enrolled. The early group included 432 patients, the middle group included 123 patients, and the late group included 69 patients. The patients had a median age of 77 years (interquartile range, 68-83), and 359 were male (57.5%). The median prehospital mRS score was 1 (interquartile range, 1-1), median National Institutes of Health Stroke Scale score on admission was 17 (interquartile range, 10-23), and median Alberta Stroke Program Early CT Score was 10 (interquartile range, 8-10). Regarding safety and efficacy, the proportions of cases with successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b-3; 85.4% vs. 92.7% vs. 88.7%; p = 0.47), symptomatic intracranial haemorrhage (6.4% vs. 5.7% vs. 7.2%; p = 0.99), mRS score ≤3 at 90 days (52.0% vs. 60.2% vs. 44.9%; p = 0.11), and mRS score of 6 at 90 days (11.3% vs. 10.6 vs. 8.7%; p = 0.37) were not significantly different between the three groups.

CONCLUSION

Patients who received MT more than 16 h after LKW experienced the same safety and efficacy as those who received MT at 0-16 h after LKW. MT more than 16 h after LKW may be safe and effective for stroke patients with LVO.

摘要

介绍

DAWN(DWI 或 CTP 评估与在神经介入治疗中进行的唤醒和迟发性卒中的临床不匹配分诊中的临床失匹配)试验报道,在最后一次已知正常(LKW)后 24 小时内进行机械血栓切除术(MT)是有效的,DEFUSE-3(血管内治疗后的缺血性中风影像学评估 3)试验报道,在 LKW 后 16 小时内进行 MT 是有效的。然而,很少有关于 LKW 后超过 16 小时的 MT 的报道,并且 LKW 后超过 24 小时的 MT 的疗效和安全性尚未得到证实。我们评估了 LKW 后超过 16 小时的 MT 的疗效和安全性。

方法

使用 2011 年 4 月至 2022 年 8 月日本医科大学医院 MT 登记处的数据,连续纳入前循环大血管闭塞(LVO)和院前改良 Rankin 量表(mRS)评分 0-3 的患者。患者被分为以下三组:早期组(LKW <6 小时)、中期组(LKW 6-16 小时)和晚期组(LKW >16 小时)。比较这三组患者的临床特征和结局。

结果

在 MT 登记处的 778 名患者中,纳入了 624 名患者。早期组包括 432 名患者,中期组包括 123 名患者,晚期组包括 69 名患者。患者的中位年龄为 77 岁(四分位距,68-83),359 名男性(57.5%)。中位院前 mRS 评分为 1(四分位距,1-1),入院时 NIHSS 评分为 17(四分位距,10-23),Alberta 卒中计划早期 CT 评分为 10(四分位距,8-10)。关于安全性和疗效,成功再灌注的比例(改良脑梗死溶栓评分 2b-3;85.4% vs. 92.7% vs. 88.7%;p = 0.47)、症状性颅内出血(6.4% vs. 5.7% vs. 7.2%;p = 0.99)、90 天 mRS 评分≤3(52.0% vs. 60.2% vs. 44.9%;p = 0.11)和 90 天 mRS 评分 6(11.3% vs. 10.6% vs. 8.7%;p = 0.37)在三组之间无显著差异。

结论

LKW 后接受 MT 治疗超过 16 小时的患者与 LKW 后 0-16 小时接受 MT 治疗的患者具有相同的安全性和疗效。LKW 后超过 16 小时的 MT 对 LVO 卒中患者可能是安全有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74a/10601849/84a100d43ee0/cee-2023-0013-0001-531153_F01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验